<DOC>
	<DOCNO>NCT01576055</DOCNO>
	<brief_summary>The primary objective randomize study evaluate safety effectiveness TIGRIS Vascular Stent treatment de novo restenotic atherosclerotic lesion , ≤ 24cm length , superficial femoral proximal popliteal artery ( SFA/PPA ) patient symptomatic peripheral arterial disease ( PAD ) .</brief_summary>
	<brief_title>Evaluation GORE TIGRIS Vascular Stent</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Rutherford Class 2 4 . Abnormal ankle brachial index ( ABI ≤0.9 ) . At least 21 year age . Reasonable expectation survival least 12 month procedure . Male , infertile female , female practice effective method prevent pregnancy . One de novo restenotic lesion SFA/PPA cumulative length visually estimate ≤24cm Arteries reference vessel diameter 4.0 6.5 mm within SFA/PPA , estimate visually . Angiographic evidence least one patent tibial artery ( &lt; 50 % stenosis angiographically ) . Guidewire successfully traverse lesion treat within true lumen distal vessel . Lesion predilated stent deployment . Prior enrollment study . Vascular access/catheterization target leg within 30 day study enrollment . Prior treatment SFA/PPA target leg stenting bypass . Flowlimiting aortoiliac disease . Additional ipsilateral femoropopliteal tibial disease , outside lesion stented , require intervention . Arterial aneurysm target leg . Comorbid condition would preclude compliance study protocol . Obstructive occlusive nonatherosclerotic disease . Creatinine great 2.5 mg/dl . Amputation metatarsal , result vascular disease , target leg . Septicemia uncontrolled infection . Contraindication anticoagulation antiplatelet therapy , include allergy heparin , history heparin induce thrombocytopenia ( HIT ) , positive platelet factor 4 ( PF4 ) antibody assay . Abnormal platelet level , i.e. , platelet count Baseline le 80,000/microliter . History coagulopathy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>Superficial Femoral Artery</keyword>
	<keyword>Proximal Popliteal Artery</keyword>
	<keyword>PAD</keyword>
	<keyword>SFA</keyword>
	<keyword>PPA</keyword>
	<keyword>Stent</keyword>
	<keyword>Gore</keyword>
	<keyword>Bare Metal Stent</keyword>
	<keyword>LifeStent</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>Heparin</keyword>
	<keyword>claudication</keyword>
	<keyword>leg pain</keyword>
</DOC>